Paliperidone palmitate and lithium induced neuroleptic malignant syndrome in a bipolar disorder patient: a case report
Mustafa İspir, Recep Tütüncü, Hakan Balıbey, Ayhan Algül, Mehmet Alpay Ateş, Yakup Yılan, Cem Öge, Cengiz Başoğlu.
Abstract
Neuroleptic Malignant Syndrome (NMS); is a rare, idiosyncratic adverse reaction which usually occurs with antipsychotic treatment. It is defined as fever, autonomic instability, extrapyramidal syndrome and altered mental state. Elevated serum creatine kinase level, impaired liver and kidney function tests, leukocytosis, and electrolyte disturbance may be the accompanying laboratory features. In this case report, we present the manifestation of NMS in a 21-year-old-man with bipolar disorder, after addition of paliperidone palmitate and lithium. To the best of our knowledge, this case is the first to report the NMS arising from the use of paliperidone palmitate and lithium in a patient with bipolar disorder.
The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
We use cookies and other tracking technologies to work properly, to analyze our website traffic, and to understand where our visitors are coming from. More InfoGot It!
